Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil

do not choose between but, rather, combine them

  • Schwartz, Eli
  • Lachish, Tamar

  • 1The Chaim Sheba Medical Center, The Center for Geographic Medicine, Tel Hashomer, Israel;

    2Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel;

    3The Infectious Diseases Unit, Shaare-Zedek Medical Center, Jerusalem, Israel

: Professor Eli Schwartz, The Chaim Sheba Medical Center, The Center for Geographic Medicine, Tel Hashomer 52621, Israel; [email protected]

Evidence Based Medicine 21(2):p 64, April 2016. | DOI: 10.1136/ebmed-2015-110183
Copyright © 2016 BMJ Publishing Group Ltd
View full text|Download PDF